Dual Role of P2 Receptors during Osteoblast Differentiation

详细信息    查看全文

• 作者：Renata Rodrigues-Ribeiro ; érika Costa Alvarenga…
• 关键词：Osteoblasts ; Purinergic receptors ; Differentiation
• 刊名：Cell Biochemistry and Biophysics
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：71
• 期：2
• 页码：1225-1233
• 全文大小：740 KB
• 参考文献：1. Alvarenga, E. C., Rodrigues, R., Caricati-Neto, A., Silva-Filho, F. C., Paredes-Gamero, E. J., & Ferreira, A. T. (2010). Low-intensity pulsed ultrasound-dependent osteoblast proliferation occurs by via activation of the P2Y receptor: role of the P2Y1 receptor. / Bone, / 46(2), 355-62. CrossRef
  2. Rumney, R. M., Sunters, A., Reilly, G. C., & Gartland, A. (2012). Application of multiple forms of mechanical loading to human osteoblasts reveals increased ATP release in response to fluid flow in 3D cultures and differential regulation of immediate early genes. / Journal of Biomechanics, / 45(3), 549-54. CrossRef
  3. Romanello, M., Codognotto, A., Bicego, M., Pines, A., Tell, G., & D’andrea, P. (2005). Autocrine/paracrine stimulation of purinergic receptors in osteoblasts: contribution of vesicular ATP release. / Biochem Biophys Res Commun, / 331(4), 1429-438. CrossRef
  4. Bowler, W. B., Buckley, K. A., Gartland, A., Hipskind, R. A., Bilbe, G., & Gallagher, J. A. (2001). Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. / Bone, / 28(5), 507-12. CrossRef
  5. Burnstock, G. (2009). Purinergic signalling: past, present and future. / Brazilian Journal of Medical and Biological Research, / 42(1), 3-. CrossRef
  6. Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., et al. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. / FEBS Letters, / 324(2), 219-25. CrossRef
  7. Nicholas, R. A., Lazarowski, E. R., Watt, W. C., Li, Q., Boyer, J., & Harden, T. K. (1996). Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. / Journal of Autonomic Pharmacology, / 16(6), 319-23. CrossRef
  8. Von Kugelgen, I., & Wetter, A. (2000). Molecular pharmacology of P2Y-receptors. / Naunyn Schmiedebergs Arch Pharmacol, / 362(4-), 310-23. CrossRef
  9. Erb, L., Lustig, K. D., Sullivan, D. M., Turner, J. T., & Weisman, G. A. (1993). Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor. / Proc Natl Acad Sci U S A, / 90(22), 10449-0453. CrossRef
  10. Communi, D., Parmentier, M., & Boeynaems, J. M. (1996). Cloning, functional expression and tissue distribution of the human P2Y6 receptor. / Biochem Biophys Res Commun, / 222(2), 303-08. CrossRef
  11. Troadec, J. D., Thirion, S., Nicaise, G., Lemos, J. R. & Dayanithi, G. (1998) ATP-evoked increases in [Ca2+]i and peptide release from rat isolated neurohypophysial terminals via a P2X2 purinoceptor. / J Physiol, / 511(Pt 1), 89-03.
  12. Buell, G., Michel, A. D., Lewis, C., Collo, G., Humphrey, P. P., & Surprenant, A. (1996). P2X1 receptor activation in HL60 cells. / Blood, / 87(7), 2659-664.
  13. Gever, J. R., Cockayne, D. A., Dillon, M. P., Burnstock, G., & Ford, A. P. (2006). Pharmacology of P2X channels. / Pflugers Archiv. European Journal of Physiology, / 452(5), 513-37. CrossRef
  14. Wiley, J. S., Chen, J. R., Snook, M. B., & Jamieson, G. P. (1994). The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP. / British Journal of Pharmacology, / 112(3), 946-50. CrossRef
  15. Jin, J., Tomlinson, W., Kirk, I. P., Kim, Y. B., Humphries, R. G., & Kunapuli, S. P. (2001). The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor. / British Journ
• 刊物主题：Biochemistry, general; Pharmacology/Toxicology; Biotechnology; Cell Biology; Biophysics and Biological Physics;
• 出版者：Springer US
• ISSN：1559-0283

文摘

P2 receptors activated by ATP are expressed in the skeletal system. However, the role of P2 receptors in osteoblast differentiation remains unclear. Methods: Participation of P2 receptors in differentiation was investigated in the preosteoblast MC3T3-M1 cell line. Preosteoblasts were stimulated for 7 or 14?days in the presence of osteogenic medium containing ATP and its analogs, and then alkaline phosphatase (ALP) activity, gene expression analyses, and protein expression were assessed. Results: We observed that ATP and its analogs promoted increased ALP activity after 7?days of treatment. In contrast, these agonists promoted reductions in ALP activity after 14?days. Some antagonists, such as PPADS (P2 antagonist), MRS2179 (P2Y1 antagonist), MRS2578 (P2Y6 antagonist), and AZ11645373 (P2X7 antagonist) reduced the increases in ALP activity after 7?days. However, only AZ11645373 inhibited the reduction in ALP activity after 14?days. The expression of the P2Y2, P2Y6, P2X4, and P2X7 receptors was observed. Furthermore, treatment with ATP modulated the expression of P2 receptors, increasing P2X4 expression and reducing P2Y6 and P2X7 expression. Similar results were observed after 14?days. In addition, ATP treatment for 7?days increased the expression of transcription factors associated with osteoblast differentiation, such as Runx2, SP7, and Dix5, whereas SP7 and Dix5 expression was reduced at 14?days. These results suggest that P2 receptor activation modulates the differentiation of osteoblasts and is dependent upon the stage of differentiation. These results also suggest that several P2 receptors are involved in this process.